Services Division works with these divisions to provide technological approaches, including genomics, proteomics and bioinformatics. There is also the Public Health Risk Sciences Division, which is a specialized resource that provides scientific knowledge and solutions to better assess public health risks and enable decisions, with specific attention to infectious disease threats transmitted from food, the animals, or the physical environment. These science-based divisions are complemented and supported by numerous other units that ensure their ongoing operations such as the Office of Science Planning, Program Support and Services, Scientific Informatic Services, Science Support and Client Services, Surveillance and References Services, the Facility and Property Management Division, and the Biorisk and Occupational Safety Services Division. NML also funds the National Reference Centre for Parasitology in Montreal and has a Laboratory Liaison Technical Officer in most provincial labs. Workforce NML employs scientists (MD, PhD, and DVM), biologists, and laboratory technologists, but it also includes informatics specialists, biosafety experts, specialized operations and maintenance staff, and administrative staff, among others. In total, there are approximately 600 staff members as of 2016. The laboratory has collaborated with scientists from People's Liberation Army from at least 2016 to 2020. Accomplishments NML is renowned for its work on a broad spectrum of infectious diseases from seasonal influenza to Ebola and its accomplishments are too many to detail. Some recent examples of the work done by NML include their involvement in the response to the West African Ebola outbreak. For a period of about 18 months, teams from NML travelled to West Africa to aid in the diagnostics during the outbreak. They worked closely with the World Health Organization and Médecins sans frontières to ensure people were properly diagnosed so that they could be properly cared for and isolated from others to stop the spread. Also during this outbreak, a promising vaccine and treatment for Ebola that were developed at NML, in conjunction with collaborators, were fast tracked into clinical trials so that they could get to the people that needed it as soon as possible. Another accomplishment was the response to the 2009 H1N1 influenza pandemic. In April 2009, the Mexican national lab approached NML for assistance with identifying a respiratory virus that was causing outbreaks in Mexico. NML was able to quickly identify the new virus and recognize that it matched the virus that was beginning to circulate in the U.S. As the lead laboratory in Canada,